These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9022027)

  • 21. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
    Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
    Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
    J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V; Elias D; Reshef T; Cohen IR
    J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic mice.
    Wang JL; Qian X; Chinookoswong N; Lu J; Chow G; Theill LE; Shi ZQ
    Endocrinology; 2002 Sep; 143(9):3490-7. PubMed ID: 12193562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
    Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
    J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.
    Garcia I; Miyazaki Y; Araki K; Araki M; Lucas R; Grau GE; Milon G; Belkaid Y; Montixi C; Lesslauer W
    Eur J Immunol; 1995 Aug; 25(8):2401-7. PubMed ID: 7664802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin does not alter diabetes incidence in the NOD mouse.
    Beales PE; Giorgini A; Annovazzi A; Signore A; Parlapiano C; Pozzilli P
    Horm Metab Res; 1997 Jun; 29(6):261-3. PubMed ID: 9230345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.
    Walter U; Franzke A; Sarukhan A; Zober C; von Boehmer H; Buer J; Lechner O
    Eur J Immunol; 2000 Apr; 30(4):1224-32. PubMed ID: 10760812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
    Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
    Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor.
    Wu Q; Salomon B; Chen M; Wang Y; Hoffman LM; Bluestone JA; Fu YX
    J Exp Med; 2001 Jun; 193(11):1327-32. PubMed ID: 11390440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb.
    Hasegawa Y; Yokono K; Taki T; Amano K; Tominaga Y; Yoneda R; Yagi N; Maeda S; Yagita H; Okumura K
    Int Immunol; 1994 Jun; 6(6):831-8. PubMed ID: 7916204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.
    Green EA; Flavell RA
    Immunol Rev; 1999 Jun; 169():11-22. PubMed ID: 10450504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.
    Higuchi Y; Herrera P; Muniesa P; Huarte J; Belin D; Ohashi P; Aichele P; Orci L; Vassalli JD; Vassalli P
    J Exp Med; 1992 Dec; 176(6):1719-31. PubMed ID: 1460428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model.
    Sytwu HK; Lin WD; Roffler SR; Hung JT; Sung HS; Wang CH; Cheng TL; Tsou SC; Hsi SC; Shen KL
    J Autoimmun; 2003 Nov; 21(3):247-54. PubMed ID: 14599849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development.
    Jacob CO; Aiso S; Schreiber RD; McDevitt HO
    Int Immunol; 1992 May; 4(5):611-4. PubMed ID: 1510787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daintain/AIF-1 (Allograft Inflammatory Factor-1) accelerates type 1 diabetes in NOD mice.
    Zhao YY; Huang XY; Chen ZW
    Biochem Biophys Res Commun; 2012 Oct; 427(3):513-7. PubMed ID: 23022189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.